Ironwood Pharmaceuticals Inc
IRWD· Nasdaq
Released Aug 6, 2026, before the open
10-Q filed Aug 6, 2026, 37 days after period end · 0001104659-26-091987
| Metric | Q2 2026 | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $113.04M | $85.24M | $94.40M | $107.38M |
| Net Income | $51.29M | $23.60M | -$860.00K | -$1.06B |
| EPS Diluted |
Ironwood Pharmaceuticals Inc · CIK 1446847 · Engraved from SEC EDGAR
| $0.31 |
| $0.14 |
| -$0.01 |
| -$6.84 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.